Topic

) and and Lavan Thasarathakumar, Thasa Consulting.

Articles

Hannah Schofield and Lavan Thasarathakumar discuss what blockchain is, how it could help improve pharmaceutical supply chains, and the COVID-19 vaccine supply chain in particular, and touches on where we are already seeing blockchain technology being used in this area.

Blockchain, COVID-19 and the Pharmaceutical Supply Chain

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at 

Amgen is collaborating on two digital health initiatives aimed at improving heart failure care and rehabilitation.

Digital Health at the Heart of the Matter

Exposing the truth behind AI myths highlighted by COVID.

Top 5 Most Perpetuated AI Myths, Debunked

Paul Riley is Medical Affairs director at Glasshouse Health, a specialist Medical Affairs consulting practice based in Alderley Park, Macclesfield, UK. 

Colin Baughman is founder and managing partner at True North Solutions Inc., a Medical Affairs Analytics & AI consulting practice based in Cambridge, Massachusetts, USA.

Jeff Catlin is co-founder and CEO of Lexalytics, and has more than 20 years of experience in the fields of search, classification and text analytics products and services. 

Treating medical affairs solely as a support function is penny-wise and pound foolish. With the advent of machine learning, the medical affairs team can innovate and perform their many functions better and more efficiently.

     Medical Affairs: Support Function or Competitive Advantage? How AI & NLP Can Ensure It is Both

In this roundtable discussion, Steve Gens, Remco Munnik and James Kelleher explore the potential and the practicalities of building future processes on a single, joined-up content platform.

Is More Fluid Data & Document Management the Answer to Life Sciences Process Transformation?

New data comparing past vs. present experience with telemedicine during the pandemic uncovers insight on how patients, doctors, and payers view the market post-COVID.

The Future of Telehealth: Evolving COVID Perspectives Offer Clues

A coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction.

In Silico in Sight as Biopharma Game-Changer

André Sode, CEO of Liva Healthcare, talks about Liva’s collaboration with Amgen to co-create an innovative digital tele-rehabilitation solution called Rehab+.

Amgen and Liva Healthcare Partner for Innovative Digital Tele-Rehabilitation Solution

The drug development sector is embracing technologies and digital methods that were previously not as widely used due to the COVID-19 global health crisis.

Anticipating Digital Transformation of the Drug Development Workforce

Tahel Noy, Ph.D. and Bill Woywod, MPH, MBA are associate directors in the Life Sciences practice at 

Merging strengths of traditional behavioral and attitudinal research, capability enables pharmaceutical field teams to prioritize resources, targets, and outreach strategies.

Technology